Disclosed in a recent SEC filing on February 14, Jessup, Director at CorVel (NASDAQ:CRVL), made a noteworthy transaction involving the exercise of company stock options.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Jessup, Director at CorVel, a company in the Health Care sector, just exercised stock options worth 3,000 shares of CRVL stock with an exercise price of $40.57.
Currently, CorVel shares are trading down 0.0%, priced at $246.22 during Thursday's morning. This values Jessup's 3,000 shares at $616,950.
Delving into CorVel's Background
CorVel Corp applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies and government agencies in managing worker's compensation and health, auto and liability services. The company's solutions combine integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.
Understanding the Numbers: CorVel's Finances
Revenue Growth: CorVel's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 12.78%. ...